Image Source: Facebook
Zenith Drugs Ltd. has announced that its new manufacturing facility in Indore, Madhya Pradesh is on track to commence full-scale production by September 30, 2025. The facility, which has been under construction since early 2024, will significantly expand the company’s production capacity, focusing on tablet and liquid oral formulations.
Facility Location & Expansion Plans:
-
The new plant is located in Muradpura, Depalpur, Indore, strategically positioned to enhance logistics and distribution.
-
The facility will increase Zenith Drugs’ production capacity, catering to domestic and international markets.
Product Portfolio & Market Strategy:
-
The plant will manufacture a range of pharmaceutical products, including tablets, syrups, and injectables.
-
Zenith Drugs is expanding its oncology division, with a dedicated production line for cancer treatments expected by FY27.
Financial Growth & Investment:
-
The company’s revenue surged 15.8% YoY, reaching ₹132 crore in FY24.
-
Net profit doubled to ₹10 crore, reflecting strong operational efficiency.
Stock Market Reaction:
Following the announcement, Zenith Drugs’ stock jumped 11.1%, trading at ₹90 on NSE.
Future Outlook:
The company aims to ramp up production gradually, with full utilization expected by FY26.
Plans include introducing injectables, strengthening its presence in high-margin pharmaceutical segments.
Zenith Drugs’ new manufacturing facility marks a major milestone, reinforcing its commitment to innovation and market expansion.
Source:Economic Times, Trade Brains, and ValuePickr Forum.
Advertisement
Advertisement